20-F
Annual Report (Foreign)
MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES cO., LTD. MHUAF
0001213900-26-049081
- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2025 · Dec 31, 2025 | 376.04K sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 273.72K sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2023 | 239.4K sh |
| Shares Outstanding | FY 2025 · Dec 31, 2025 | 697.91K sh |
| Capex | FY 2025 · Dec 31, 2025 | $15.63K |
| Capex | FY 2025 · Dec 31, 2024 | $133.55K |
| Capex | FY 2025 · Dec 31, 2023 | $1.18M |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | $569.88K |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | $14.64M |
| Operating Cash Flow | FY 2025 · Dec 31, 2023 | $2.28M |
| Short Term Debt | FY 2025 · Dec 31, 2025 | ¥62.85M |
| Short Term Debt | FY 2025 · Dec 31, 2025 | $8.99M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | ¥58M |
| Short Term Debt | FY 2025 · Dec 31, 2024 | $7.95M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $188.93M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $158.98M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $18.25M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $27.26M |
| Current Assets | FY 2025 · Dec 31, 2025 | $153.58M |
| Current Assets | FY 2025 · Dec 31, 2024 | $143.44M |
| Total Assets | FY 2025 · Dec 31, 2025 | $207.18M |
| Total Assets | FY 2025 · Dec 31, 2024 | $186.24M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | $18.04 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | $39.62 |
| Eps Diluted restated | FY 2025 · Dec 31, 2023 | $48.56 |
| Eps Basic | FY 2025 · Dec 31, 2025 | $18.04 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | $39.62 |
| Eps Basic restated | FY 2025 · Dec 31, 2023 | $48.56 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $3.21M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $7.78M |
| Sga Expense | FY 2025 · Dec 31, 2023 | $6.54M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $2.38M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $3.46M |
| Rd Expense | FY 2025 · Dec 31, 2023 | $2.75M |
| Net Income | FY 2025 · Dec 31, 2025 | $6.78M |
| Net Income | FY 2025 · Dec 31, 2024 | $10.84M |
| Net Income | FY 2025 · Dec 31, 2023 | $11.63M |
| Operating Income | FY 2025 · Dec 31, 2025 | $8.28M |
| Operating Income | FY 2025 · Dec 31, 2024 | $14.31M |
| Operating Income | FY 2025 · Dec 31, 2023 | $14.67M |
| Gross Profit | FY 2025 · Dec 31, 2025 | $19.16M |
| Gross Profit | FY 2025 · Dec 31, 2024 | $33.3M |
| Gross Profit | FY 2025 · Dec 31, 2023 | $33.2M |
| Cost Of Revenue | FY 2025 · Dec 31, 2025 | $42.63M |
| Cost Of Revenue | FY 2025 · Dec 31, 2024 | $63.61M |
| Cost Of Revenue | FY 2025 · Dec 31, 2023 | $63.9M |
| Revenue | FY 2025 · Dec 31, 2025 | $61.79M |
| Revenue | FY 2025 · Dec 31, 2024 | $96.91M |
| Revenue | FY 2025 · Dec 31, 2023 | $97.1M |
| Stock Repurchased | FY 2025 · Dec 31, 2024 | $200K |